LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 1 | M06 | 72 | hr | 1389 | 6820 | 5147 | 1.3250 | 1.3212 |
| Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 3 | B10 | 72 | hr | 765 | 3850 | 3066 | 1.2557 | 1.2408 |
| Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 2 | B09 | 72 | hr | 765 | 3882 | 3095 | 1.2540 | 1.2376 |
| Hs 578T | SB590885 | 3.33 | uM | LJP5 | 3 | L14 | 72 | hr | 765 | 3935 | 3152 | 1.2482 | 1.2293 |
| Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 3 | B09 | 72 | hr | 765 | 3821 | 3066 | 1.2462 | 1.2324 |
| MCF7 | Celastrol | 0.04 | uM | LJP6 | 1 | G12 | 72 | hr | 1389 | 6372 | 5147 | 1.2380 | 1.2392 |
| Hs 578T | SB590885 | 0.12 | uM | LJP5 | 2 | L17 | 72 | hr | 765 | 3890 | 3151 | 1.2343 | 1.2171 |
| Hs 578T | PLX-4720 | 0.37 | uM | LJP5 | 2 | K04 | 72 | hr | 765 | 3881 | 3151 | 1.2314 | 1.2146 |
| Hs 578T | SB590885 | 0.04 | uM | LJP5 | 1 | L18 | 72 | hr | 765 | 3860 | 3140 | 1.2292 | 1.2132 |
| Hs 578T | SB590885 | 3.33 | uM | LJP5 | 2 | L14 | 72 | hr | 765 | 3868 | 3151 | 1.2273 | 1.2110 |
| Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 2 | B08 | 72 | hr | 765 | 3789 | 3095 | 1.2240 | 1.2108 |
| Hs 578T | SB590885 | 0.04 | uM | LJP5 | 3 | L18 | 72 | hr | 765 | 3855 | 3152 | 1.2229 | 1.2070 |
| BT-20 | PD173074 | 3.33 | uM | LJP6 | 1 | I08 | 72 | hr | 1334 | 4823 | 3955 | 1.2192 | 1.2696 |
| Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 1 | B08 | 72 | hr | 765 | 3824 | 3143 | 1.2164 | 1.2017 |
| MCF7 | LJP6 | 1 | F08 | 72 | hr | 1389 | 6258 | 5147 | 1.2158 | 1.2179 | |||
| MCF7 | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 1389 | 6614 | 5447 | 1.2140 | 1.2068 |
| Hs 578T | PLX-4720 | 1.11 | uM | LJP5 | 2 | K03 | 72 | hr | 765 | 3822 | 3151 | 1.2127 | 1.1980 |
| Hs 578T | SB590885 | 1.11 | uM | LJP5 | 1 | L15 | 72 | hr | 765 | 3798 | 3140 | 1.2094 | 1.1956 |
| MCF7 | LJP6 | 1 | F12 | 72 | hr | 1389 | 6221 | 5147 | 1.2086 | 1.2110 | |||
| Hs 578T | SB590885 | 3.33 | uM | LJP5 | 1 | L14 | 72 | hr | 765 | 3791 | 3140 | 1.2072 | 1.1937 |
| Hs 578T | PLX-4720 | 0.37 | uM | LJP5 | 3 | K04 | 72 | hr | 765 | 3803 | 3152 | 1.2064 | 1.1924 |
| Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 3 | B08 | 72 | hr | 765 | 3697 | 3066 | 1.2058 | 1.1959 |
| Hs 578T | SB590885 | 1.11 | uM | LJP5 | 3 | L15 | 72 | hr | 765 | 3798 | 3152 | 1.2048 | 1.1910 |
| Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 1 | B09 | 72 | hr | 765 | 3786 | 3143 | 1.2043 | 1.1909 |
| Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 2 | B10 | 72 | hr | 765 | 3724 | 3095 | 1.2030 | 1.1919 |